Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
calcitonin gene-related peptide
chronic migraine
clinical trials
eli lilly
episodic migraine
fda
indiana blog main
indiana top stories
life sciences
national blog main
teva pharmaceutical
alder biopharmaceuticals
big data
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
business
david rind
detroit blog main
detroit top stories
drugs
eptinezumab
erenumab
eurohpc
food and drug administration
fremanezumab
galcanezumab
health tech
healthtech
hitesh badgujar
hpc
indiana
institute for clinical and economic review
machinelearning
migraine
migraine research foundation
migraines
What
developed
4
×
medicines
4
×
new
4
×
approval
class
drug
fda
migraine
pain
starts
won
aided
amgen
announced
approved
blurring
boundaries
candidates
coming
computing
customized
decade
decision
drugs
eli
exciting
fabrication
faster
gets
guest
head
headache
high
imagination
institute
late
licensed
lilly
marks
massachusetts
Language
Current search:
medicines
×
new
×
developed
×
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@DSMeu
5 years ago
New medicines could be developed faster thanks to high performance computing & #machinelearning. Read this story about an EU-supported project http://bit.ly/2Or4zRH #EuroHPC #HPC #HealthTech https://t.co/gf62ur9HCL
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@venturebeat.com
8 years ago
Coming up next in personalized medicine: 3D printed drugs
